It can be argued that the severity of COVID‐19 has decreased in many countries. This could
be a result of the broad coverage of the population by vaccination campaigns, which often …

Age is a significant risk factor for the coronavirus disease 2019 (COVID-19) severity due to
immunosenescence and certain age-dependent medical conditions (eg, obesity …

The vast numbers of COVID-19 infections globally implies that a large number of people will
be affected by post-COVID sequelae even with conservative estimates. A significant number …

The objective of this research was to characterize menstrual changes including amount,
duration, and frequency among COVID-19 vaccinated and infected women. We conducted …

Approximately 15% of adult Canadians with SARS-CoV-2 infection develop lingering
symptoms beyond 12 weeks post-acute infection, known as post-COVID condition or long …

As COVID-19 evolves from a pandemic to an endemic disease, the already staggering
number of people that have been or will be infected with SARS-COV-2 is only destined to …

Background The long-term cardiovascular (CV) outcomes of COVID-19 have not been fully
explored. Methods This was an international, multicenter, retrospective cohort study …

With the Omicron wave, SARS-CoV-2 infections improved, with less lung involvement and
few cases of severe manifestations. In this pictorial review, there is a summary of the …

Abstract Purpose of Review Cardiovascular (CV) disease is a known complication of SARS-
CoV-2 infection. A clear benefit of COVID-19 vaccination is a reduction mortality; however …

Rationale Abnormal values of hypercoagulability biomarkers, such as D-dimer, have been
described in Coronavirus Disease 2019 (COVID-19), which has also been associated with …